296 related articles for article (PubMed ID: 30328212)
1. Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
Rowczenio D; Quarta CC; Fontana M; Whelan CJ; Martinez-Naharro A; Trojer H; Baginska A; Ferguson SM; Gilbertson J; Rezk T; Sachchithanantham S; Mahmood S; Manwani R; Sharpley F; Wechalekar AD; Hawkins PN; Gillmore JD; Lachmann HJ
Hum Mutat; 2019 Jan; 40(1):90-96. PubMed ID: 30328212
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
[TBL] [Abstract][Full Text] [Related]
4. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
[TBL] [Abstract][Full Text] [Related]
6. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis.
Chan GG; Koch CM; Connors LH
J Proteome Res; 2017 Apr; 16(4):1659-1668. PubMed ID: 28196416
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
Sikora JL; Logue MW; Chan GG; Spencer BH; Prokaeva TB; Baldwin CT; Seldin DC; Connors LH
Hum Genet; 2015 Jan; 134(1):111-21. PubMed ID: 25367359
[TBL] [Abstract][Full Text] [Related]
8. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
[TBL] [Abstract][Full Text] [Related]
9. Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis.
Moreno-Gázquez I; Pérez-Palacios R; Abengochea-Quílez L; Lahuerta Pueyo C; Roteta Unceta Barrenechea A; Andrés Gracia A; Aibar Arregui MA; Menao Guillén S
BMC Res Notes; 2023 Oct; 16(1):249. PubMed ID: 37784196
[TBL] [Abstract][Full Text] [Related]
10. Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Ikram A; Donnelly JP; Sperry BW; Samaras C; Valent J; Hanna M
Amyloid; 2018 Sep; 25(3):197-202. PubMed ID: 30388377
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.
Park GY; Jamerlan A; Shim KH; An SSA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216785
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Ruberg FL; Maurer MS
JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
[TBL] [Abstract][Full Text] [Related]
13. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
[TBL] [Abstract][Full Text] [Related]
14. Transthyretin: Its function and amyloid formation.
Ueda M
Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
[TBL] [Abstract][Full Text] [Related]
15. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
[TBL] [Abstract][Full Text] [Related]
16. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
Waddington-Cruz M; Ackermann EJ; Polydefkis M; Heitner SB; Dyck PJ; Barroso FA; Wang AK; Berk JL; Dyck PJB; Monia BP; Hughes SG; Tai L; Jesse Kwoh T; Jung SW; Coelho T; Benson MD; Gertz MA
Amyloid; 2018 Sep; 25(3):180-188. PubMed ID: 30169969
[TBL] [Abstract][Full Text] [Related]
17. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.
Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S
Circulation; 2009 Sep; 120(13):1203-12. PubMed ID: 19752327
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
19. Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.
De Lillo A; De Angelis F; Di Girolamo M; Luigetti M; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
Hum Genet; 2019 Dec; 138(11-12):1331-1340. PubMed ID: 31659433
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
